Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 32 n° 250

Posts Tagged ‘morgan’

Analog Devices to Participate in the J.P. Morgan Tech/Auto Forum

Posted by fidest press agency su domenica, 5 gennaio 2020

Analog Devices, Inc. (Nasdaq: ADI), a leading global high performance analog technology company, today announced that the Company’s Senior Vice President, Finance and Chief Financial Officer, Prashanth Mahendra-Rajah, will speak at the J.P. Morgan 18th Annual Tech/Auto Forum at the 2020 International Consumer Electronics Show in Las Vegas, Nevada on Tuesday, January 7, 2020, at 11:50 a.m. Pacific Time.The audio webcast for the conference may be accessed live via the Investor Relations section of Analog Devices’ website at investor.analog.com. An archived replay will also be available shortly following the webcast.
Analog Devices (Nasdaq: ADI) is a leading global high-performance analog technology company dedicated to solving the toughest engineering challenges. We enable our customers to interpret the world around us by intelligently bridging the physical and digital with unmatched technologies that sense, measure, power, connect and interpret. Visit http://www.analog.com.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

38th Annual J.P. Morgan Healthcare Conference

Posted by fidest press agency su domenica, 22 dicembre 2019

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the 38th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis in San Francisco on Wednesday, January 15, 2020, at 11:00 a.m. Pacific time (2:00 p.m. Eastern time).
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 19,000 Team Schein Members worldwide, the Company’s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

38th Annual J.P. Morgan Healthcare Conference

Posted by fidest press agency su domenica, 8 dicembre 2019

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco. José (Joe) E. Almeida, Baxter’s chairman and chief executive officer, is scheduled to present on Monday, January 13, 2020 at 10:00 a.m. Pacific Time.The live webcast of Baxter’s presentation, along with accompanying slides, can be accessed at http://www.baxter.com and will be available for replay through July 11, 2020. Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit http://www.baxter.com and follow us on Twitter, LinkedIn and Facebook.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

J.P. Morgan Ultimate Services Investor Conference

Posted by fidest press agency su sabato, 9 novembre 2019

Raymond McDaniel Jr., President and Chief Executive Officer of Moody’s Corporation (NYSE: MCO), will speak at the J.P. Morgan Ultimate Services Investor Conference on Wednesday, November 13, 2019 in New York. Mr. McDaniel’s presentation will begin at approximately 10:30 a.m. Eastern Time. The presentation will be webcast live and may include forward-looking statements. The webcast can be accessed at Moody’s Investor Relations website, ir.moodys.com.
Moody’s is an essential component of the global capital markets, providing credit ratings, research, tools and analysis that contribute to transparent and integrated financial markets. Moody’s Corporation (NYSE:MCO) is the parent company of Moody’s Investors Service, which provides credit ratings and research covering debt instruments and securities, and Moody’s Analytics, which offers leading-edge software, advisory services and research for credit and economic analysis and financial risk management. The corporation, which reported revenue of $4.4 billion in 2018, employs approximately 13,700 people worldwide and maintains a presence in 44 countries. Further information is available at http://www.moodys.com.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Morgan Stanley Global Healthcare Conference

Posted by fidest press agency su giovedì, 29 agosto 2019

CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the Morgan Stanley 17th Annual Global Healthcare Conference at 1:30 p.m. ET on Tuesday, September 10, 2019 in New York, NY. A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at http://www.conmed.com and will be available for replay following the event.
CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery and gastroenterology. For more information, visit http://www.conmed.com.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

Morgan County Alabama Joins List as 6th County to Accept Online Filings

Posted by fidest press agency su sabato, 10 agosto 2019

Morgan County joined five other Alabama counties in accepting online business filings through the Secretary of State. The online suite of services, built in partnership with Alabama Interactive, allows people to fully form domestic LLCs and corporations online. Participating counties can take advantage of the one-stop filing system the online suite of services creates for business filings.Citizens no longer have to wait days or months to complete the process of starting a business through the Secretary of State’s office. Customers that file businesses online receive official copies of their Name Reservation and Formation certificates immediately following completion of the application. The Domestic Pre-Filing application is still available to counties and business entity types that have not yet adopted the online filing feature.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

47th Annual J.P. Morgan Global Technology, Media and Communications Conference

Posted by fidest press agency su mercoledì, 8 maggio 2019

F5 Networks, Inc. (NASDAQ: FFIV) announced that it will participate in the 47th Annual J.P. Morgan Global Technology, Media and Communications Conference in Boston, Mass.F5’s presentation, beginning at 10:00 a.m. ET on Tuesday, May 14, 2019, will be webcast live. Interested listeners can access the live webcast via the IR page on F5.com or via this link. An archived version of the webcast will be available on F5’s IR page through June 13, 2019.
F5 (NASDAQ: FFIV) gives the world’s largest businesses, service providers, governments, and consumer brands the freedom to securely deliver every app, anywhere—with confidence. F5 delivers cloud and security application services that enable organizations to embrace the infrastructure they choose without sacrificing speed and control. For more information, go to f5.com. You can also follow @f5networks on Twitter or visit us on LinkedIn and Facebook for more information about F5, its partners, and technologies. F5 is a trademark and service mark of F5 Networks, Inc., in the U.S. and other countries. All other product and company names herein may be trademarks of their respective owners.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

37th Annual J.P. Morgan Healthcare Conference

Posted by fidest press agency su giovedì, 3 gennaio 2019

San Francisco on Wednesday, January 9, 2019 Time: 11:00 a.m. PT Westin St. Francis, Elizabethan D. Merck (NYSE:MRK), Morphic Therapeutic, a biotechnology company developing a new generation of oral integrin therapies, announced today that the company will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco Praveen Tipirneni, M.D., president and CEO of Morphic, will provide an overview of the company, its innovative platform for designing integrin oral inhibitors, and anticipated milestones in 2019.Morphic is developing highly differentiated molecules for the treatment of autoimmune diseases, fibrotic diseases, and cancer. In 2018, Morphic announced the completion of a $80 million Series B financing and entered into a research and development collaboration with AbbVie designed to advance a number of Morphic’s oral integrin therapeutics for fibrosis-related indications.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

Sage Therapeutics to Present at J.P. Morgan Healthcare Conference

Posted by fidest press agency su sabato, 29 dicembre 2018

Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that the Company will present at the J.P. Morgan 2019 Healthcare Conference in San Francisco, Calif. on Tuesday, January 8, 2019 at 3:30 p.m. PST (6:30 p.m. EST), followed by a Q&A session.A live webcast of the presentation can be accessed on the investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will also be archived for up to 30 days on Sage’s website following the conference.Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering CNS disorders. Sage’s lead product candidate, ZULRESSO™ (brexanolone) injection, has completed Phase 3 clinical development for postpartum depression and a New Drug Application is currently under review with the U.S. Food and Drug Administration. Sage is developing a portfolio of novel product candidates targeting critical CNS receptor systems, including SAGE-217, which is in Phase 3 development in major depressive disorder and postpartum depression. For more information, please visit http://www.sagerx.com.

Posted in Estero/world news, Uncategorized | Contrassegnato da tag: , , | Leave a Comment »

37th Annual J.P. Morgan Healthcare Conference

Posted by fidest press agency su domenica, 23 dicembre 2018

Novocure (NASDAQ: NVCR) will participate in the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 9, 2019, in San Francisco. William Doyle, Novocure’s Executive Chairman, will speak on behalf of the company and address questions from analysts. He is scheduled to present at 2:30 p.m. PST.A live audio webcast of the presentation and all presentation materials can be access from the Investor Relations page of Novocure’s website, http://www.novocure.com/investor-relations/, and will be available for replay for at least 14 days following the event.Novocure is an oncology company developing a profoundly different cancer treatment utilizing a proprietary therapy called Tumor Treating Fields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Novocure’s commercialized product is approved for the treatment of adult patients with glioblastoma. Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer and mesothelioma.Headquartered in Jersey, Novocure has U.S. operations in Portsmouth, New Hampshire, Malvern, Pennsylvania and New York City. Additionally, the company has offices in Germany, Switzerland, Japan and Israel. For additional information about the company, please visit http://www.novocure.com or follow us at http://www.twitter.com/novocure.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

37th Annual J.P. Morgan Healthcare Conference

Posted by fidest press agency su venerdì, 21 dicembre 2018

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 8, 2019 at 11:30 a.m. Pacific Time (PT). The presentation will be followed by a Q&A session at noon PT.
The presentation and Q&A session will be webcast live and may be accessed through the investors section of Hologic’s website at http://investors.hologic.com. The webcasts will be available for 30 days.
Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit http://www.hologic.com

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Medidata to Present at the 46th Annual J.P. Morgan Global Technology

Posted by fidest press agency su domenica, 13 maggio 2018

Medidata (NASDAQ:MDSO) announced that Tarek Sherif, chairman and chief executive officer, will present at the 46th Annual J.P. Morgan Global Technology, Media and Communication Conference on Wednesday, May 16, 2018, at 3:00 p.m. ET in Boston, Mass.A live audio webcast and replay will be available at http://investor.mdsol.com.
Medidata’s unified platform, pioneering analytics, and unrivaled expertise power the development of new therapies for over 1,000 pharmaceutical companies, biotech, medical device firms, academic medical centers and contract research organizations around the world. The Medidata Clinical Cloud® connects patients, physicians and life sciences professionals. Companies on the Medidata platform are individually and collaboratively reinventing the way research is done to create smarter, more precise treatments. For more information: http://www.mdsol.com

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »